tiprankstipranks
Advertisement
Advertisement
BridgeBio Oncology Overhauls Leadership for Next Development Phase
PremiumCompany AnnouncementsBridgeBio Oncology Overhauls Leadership for Next Development Phase
1M ago
BridgeBio Oncology appoints Pedro Beltran as CEO, Idan Elmelech as COO
Premium
The Fly
BridgeBio Oncology appoints Pedro Beltran as CEO, Idan Elmelech as COO
1M ago
BridgeBio Oncology announces FDA Fast Track Designation for BBO-11818
Premium
The Fly
BridgeBio Oncology announces FDA Fast Track Designation for BBO-11818
2M ago
BridgeBio Oncology initiated with a Buy at Stifel
PremiumThe FlyBridgeBio Oncology initiated with a Buy at Stifel
4M ago
BridgeBio Oncology initiated with an Outperform at Raymond James
Premium
The Fly
BridgeBio Oncology initiated with an Outperform at Raymond James
5M ago
BridgeBio Oncology price target lowered to $18 from $20 at Morgan Stanley
Premium
The Fly
BridgeBio Oncology price target lowered to $18 from $20 at Morgan Stanley
5M ago
BridgeBio Oncology: Positioned for Growth with Innovative RAS-Targeted Therapies
PremiumRatingsBridgeBio Oncology: Positioned for Growth with Innovative RAS-Targeted Therapies
6M ago
BridgeBio Oncology Therapeutics Reports Q3 2025 Progress
Premium
Company Announcements
BridgeBio Oncology Therapeutics Reports Q3 2025 Progress
7M ago
BridgeBio Oncology price target lowered to $22 from $23 at Oppenheimer
Premium
The Fly
BridgeBio Oncology price target lowered to $22 from $23 at Oppenheimer
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100